Harun Kundi
Beth Israel Deaconess Medical Center
78 Papers
239 Citations
Harun Kundi is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Medicine & Coronary artery disease. The author has an hindex of 17, co-authored 72 publications. Previous affiliations of Harun Kundi include Harvard University & Turkish Ministry of Health.
Chat about Author
Papers
A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis.
Harun Kundi,Ihsan Ates,Emrullah Kiziltunc,Mustafa Çetin,Hulya Cicekcioglu,Salim Neselioglu,Ozcan Erel,Ender Örnek +7 more
TL;DR: In this article, a novel oxidative stress marker (thiol/disulphide homeostasis) was investigated in patients with acute myocardial infarction (AMI) and compared the results with healthy controls.
198
Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.
Eric A. Secemsky,Eric A. Secemsky,Harun Kundi,Ido Weinberg,Michael R. Jaff,Anna K. Krawisz,Anna K. Krawisz,Sahil A. Parikh,Joshua A. Beckman,Jihad Mustapha,Kenneth Rosenfield,Robert W. Yeh,Robert W. Yeh +12 more
TL;DR: In this large nationwide analysis of Centers for Medicare and Medicaid Services beneficiaries, there was no evidence of increased all-cause mortality following femoropopliteal artery revascularization with drug- coated devices compared with non–drug-coated devices.
Association of Frailty With 30-Day Outcomes for Acute Myocardial Infarction, Heart Failure, and Pneumonia Among Elderly Adults.
Harun Kundi,Rishi K. Wadhera,Rishi K. Wadhera,Jordan B. Strom,Linda R. Valsdottir,Changyu Shen,Dhruv S. Kazi,Robert W. Yeh +7 more
TL;DR: Among Medicare fee-for-service beneficiaries, frailty as measured by the Hospital Frailty Risk Score (HFRS) was associated with mortality and readmissions among patients hospitalized for AMI, HF, or pneumonia.
The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
Harun Kundi,Elif Hande Ozcan Cetin,Uğur Canpolat,Sevgi Aras,Osman Celik,Naim Ata,Suayip Birinci,Serkan Cay,Ozcan Ozeke,Ibrahim Halil Tanboga,Serkan Topaloglu +10 more
TL;DR: As a claims-based frailty model, the HFRS provides clinicians and health systems, a standardized tool for an effective detection and grading of frailty in patients in COVID-19, and may provide a more accurate risk categorization for both therapeutic and preventive strategies.
104
Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease.
Harun Kundi,Emrullah Kiziltunc,Mustafa Çetin,Hulya Cicekcioglu,Zehra Güven Çetin,Gökhan Çiçek,Ender Örnek +6 more
TL;DR: The results suggest that MHR can be used as a prognostic marker in patients with stable CAD, since it is an easily available and inexpensive test.
97